Evidence map›Paper›PMID 26335909›Full record

ArticlePain2016

Alterations in the rostral ventromedial medulla after the selective ablation of μ-opioid receptor expressing neurons.

Ichiro Harasawa, Joshua P Johansen, Howard L Fields, Frank Porreca, Ian D Meng

Open access · greenAbstract read
In one paragraph

Article in Pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. What do monoamines do in pain modulation?Current opinion in supportive and palliative care · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Ichiro HarasawaDepartment of Neurology, University of California, San Francisco, CA, USA RIKEN Brain Science Institute, Laboratory for Neural Circuitry of Memory, Saitama, Japan Department of Life Sciences, Graduate School of Arts and Sciences, University of Tokyo, Tokyo, Japan Department of Pharmacology, College of Medicine, University of Arizona, Health Sciences Center, Tucson, AZ, USA Department of Biomedical Sciences, College of Osteopathic Medicine, and the Center for Excellence in the Neurosciences, University of New England, Biddeford, ME, USA.
Joshua P Johansen
Howard L Fields
Frank Porreca
Ian D Meng
University of California, San Francisco · USThe University of Tokyo · JPUniversity of Arizona · USUniversity of New England · US

Funding

Tissue resident macrophages in sensory ganglia: function and impact on nociceptionP20GM103643 · NIGMS · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2012 to 2021
$20.9M
Brain reward circuits and relief of ongoing painR01DA034975 · NIDA · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2013 to 2017
$2.8M
Mechanism of Medication Overuse Headache and Chronic Migraine PainR01NS069572 · NINDS · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2010 to 2014
$2.3M
Chronic morphine-induced sensitization of trigeminal dura sensitive neuronsR01DA021193 · NIDA · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2007 to 2010
$1.2M
Trigeminal Mechanisms of Cannabinoid AnalgesiaR01DA014548 · NIDA · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2002 to 2005
$819k
NIDA NIH HHS R01 DA014548NIDA NIH HHS R01DA014548NIDA NIH HHS R01 DA021193NIDA NIH HHS R01 DA034975NIDA NIH HHS R01DA034975NIGMS NIH HHS P20 GM103643NIGMS NIH HHS P20GM103643NINDS NIH HHS R01 NS069572
6 · The paper itself

Abstract

The rostral ventromedial medulla (RVM) exerts both inhibitory and excitatory controls over nociceptive neurons in the spinal cord and medullary dorsal horn. Selective ablation of mu-opioid receptor (MOR)-expressing neurons in the RVM using saporin conjugated to the MOR agonist dermorphin-saporin (derm-sap) attenuates stress and injury-induced behavioral hypersensitivity, yet the effect of RVM derm-sap on the functional integrity of the descending inhibitory system and the properties of RVM neurons remain unknown. Three classes of RVM neurons (on-cells, off-cells, and neutral cells) have been described with distinct responses to noxious stimuli and MOR agonists. Using single unit recording in lightly anesthetized rats, RVM neurons were characterized after microinjections of derm-sap or saporin. Derm-sap treatment resulted in a reduction in on-cells and off-cells when compared to saporin controls (P < 0.05). The number of neutral cells remained unchanged. After derm-sap treatment, RVM microinjections of the glutamate receptor agonist homocysteic acid increased tail-flick latencies, whereas the MOR agonist DAMGO had no effect. Furthermore, electrical stimulation of the periaqueductal gray produced analgesia in both derm-sap and saporin controls with similar thresholds. Microinjection of kynurenic acid, a glutamate receptor antagonist, into the RVM disrupted periaqueductal gray stimulation-produced analgesia in both saporin-treated and derm-sap-treated rats. These results indicate that MOR-expressing neurons in the RVM are not required for analgesia produced by either direct or indirect activation of neurons in the RVM.

Indexed as

AnalgesiaAnimalsElectric StimulationMaleMedulla OblongataNeuronsNociceptorsPainPeriaqueductal GrayRatsRats, Sprague-DawleyReceptors, Opioid, muSaponinsReceptors, Opioid, muSaponins

Identifiers

PMID26335909
PMCPMC4829402
OpenAlexW2411443272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.